Literature DB >> 24435202

What's new in the controversy on the renal/tissue toxicity of starch solutions?

Norbert Lameire1, Eric Hoste.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24435202     DOI： 10.1007/s00134-013-3191-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

Review 1.  Randomised trials of 6% tetrastarch (hydroxyethyl starch 130/0.4 or 0.42) for severe sepsis reporting mortality: systematic review and meta-analysis.

Authors:  Amit Patel; Umeer Waheed; Stephen J Brett
Journal:  Intensive Care Med       Date:  2013-02-22       Impact factor: 17.440

Review 2.  Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients.

Authors:  Claude Martin; Matthias Jacob; Eric Vicaut; Bertrand Guidet; Hugo Van Aken; Andrea Kurz
Journal:  Anesthesiology       Date:  2013-02       Impact factor: 7.892

Review 3.  Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.

Authors:  Thomas C Mutter; Chelsea A Ruth; Allison B Dart
Journal:  Cochrane Database Syst Rev       Date:  2013-07-23

Review 4.  Colloids versus crystalloids for fluid resuscitation in critically ill patients.

Authors:  Pablo Perel; Ian Roberts; Katharine Ker
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 5.  Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.

Authors:  Ryan Zarychanski; Ahmed M Abou-Setta; Alexis F Turgeon; Brett L Houston; Lauralyn McIntyre; John C Marshall; Dean A Fergusson
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

6.  Hydroxyethyl starch or saline for fluid resuscitation in intensive care.

Authors:  John A Myburgh; Simon Finfer; Rinaldo Bellomo; Laurent Billot; Alan Cass; David Gattas; Parisa Glass; Jeffrey Lipman; Bette Liu; Colin McArthur; Shay McGuinness; Dorrilyn Rajbhandari; Colman B Taylor; Steven A R Webb
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

7.  Effects of hydroxyethyl starch in subgroups of patients with severe sepsis: exploratory post-hoc analyses of a randomised trial.

Authors:  Rasmus G Müller; Nicolai Haase; Jørn Wetterslev; Anders Perner
Journal:  Intensive Care Med       Date:  2013-09-14       Impact factor: 17.440

Review 8.  Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis.

Authors:  Nicolai Haase; Anders Perner; Louise Inkeri Hennings; Martin Siegemund; Bo Lauridsen; Mik Wetterslev; Jørn Wetterslev
Journal:  BMJ       Date:  2013-02-15

Review 9.  Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis.

Authors:  M A Gillies; M Habicher; S Jhanji; M Sander; M Mythen; M Hamilton; R M Pearse
Journal:  Br J Anaesth       Date:  2013-09-17       Impact factor: 9.166

10.  Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.

Authors:  Piotr Wittbrodt; Nicolai Haase; Dominika Butowska; Robert Winding; Jesper B Poulsen; Anders Perner
Journal:  Crit Care       Date:  2013-02-25       Impact factor: 9.097
View more
  2 in total

1.  Therapeutic management of peritonitis: a comprehensive guide for intensivists.

Authors:  P Montravers; S Blot; G Dimopoulos; C Eckmann; P Eggimann; X Guirao; J A Paiva; G Sganga; J De Waele
Journal:  Intensive Care Med       Date:  2016-03-16       Impact factor: 17.440

2.  Synthesis and Biological Evaluation of a Degradable Trehalose Glycopolymer Prepared by RAFT Polymerization.

Authors:  Uland Y Lau; Emma M Pelegri-O'Day; Heather D Maynard
Journal:  Macromol Rapid Commun       Date:  2017-12-18       Impact factor: 5.734
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.